| Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes. M Sofuoglu, PS Portoghese, AE Takemori Journal of Pharmacology and Experimental Therapeutics 257 (2), 676-680, 1991 | 435 | 1991 |
| The effect of cannabis compared with alcohol on driving RA Sewell, J Poling, M Sofuoglu American journal on addictions 18 (3), 185-193, 2009 | 417 | 2009 |
| Cognitive enhancement as a treatment for drug addictions M Sofuoglu, EE DeVito, AJ Waters, KM Carroll Neuropharmacology 64, 452-463, 2013 | 319 | 2013 |
| Sex and menstrual cycle differences in the subjective effects from smoked cocaine in humans. M Sofuoglu, S Dudish-Poulsen, D Nelson, PR Pentel, DK Hatsukami Experimental and clinical psychopharmacology 7 (3), 274, 1999 | 289 | 1999 |
| Stress decreases the ability to resist smoking and potentiates smoking intensity and reward SA McKee, R Sinha, AH Weinberger, M Sofuoglu, ELR Harrison, ... Journal of psychopharmacology 25 (4), 490-502, 2011 | 281 | 2011 |
| Neuroscience of behavioral and pharmacological treatments for addictions MN Potenza, M Sofuoglu, KM Carroll, BJ Rounsaville Neuron 69 (4), 695-712, 2011 | 260 | 2011 |
| Norepinephrine and stimulant addiction M Sofuoglu, RA Sewell Addiction biology 14 (2), 119-129, 2009 | 205 | 2009 |
| Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population J Poling, A Oliveto, N Petry, M Sofuoglu, K Gonsai, G Gonzalez, B Martell, ... Archives of general psychiatry 63 (2), 219-228, 2006 | 204 | 2006 |
| Cognitive enhancement as a pharmacotherapy target for stimulant addiction M Sofuoglu Addiction 105 (1), 38-48, 2010 | 182 | 2010 |
| Novel approaches to the treatment of cocaine addiction M Sofuoglu, TR Kosten CNS drugs 19 (1), 13-25, 2005 | 157 | 2005 |
| Treatment outcome predictors for cocaine dependence J Poling, TR Kosten, M Sofuoglu The American journal of drug and alcohol abuse 33 (2), 191-206, 2007 | 145 | 2007 |
| The drug effects questionnaire: psychometric support across three drug types ME Morean, H de Wit, AC King, M Sofuoglu, SY Rueger, SS O’Malley Psychopharmacology 227 (1), 177-192, 2013 | 144 | 2013 |
| Tiagabine increases cocaine‐free urines in cocaine‐dependent methadone‐treated patients: results of a randomized pilot study G Gonzalez, K Sevarino, M Sofuoglu, J Poling, A Oliveto, K Gonsai, ... Addiction 98 (11), 1625-1632, 2003 | 135 | 2003 |
| Effects of progesterone treatment on smoked cocaine response in women M Sofuoglu, DA Babb, DK Hatsukami Pharmacology Biochemistry and Behavior 72 (1-2), 431-435, 2002 | 132 | 2002 |
| Cognitive effects of nicotine: recent progress G Valentine, M Sofuoglu Current neuropharmacology 16 (4), 403-414, 2018 | 129 | 2018 |
| Role of progesterone in nicotine addiction: evidence from initiation to relapse. WJ Lynch, M Sofuoglu Experimental and clinical psychopharmacology 18 (6), 451, 2010 | 127 | 2010 |
| Emerging pharmacological strategies in the fight against cocaine addiction M Sofuoglu, TR Kosten Expert opinion on emerging drugs 11 (1), 91-98, 2006 | 124 | 2006 |
| Effects of progesterone treatment on cocaine responses in male and female cocaine users M Sofuoglu, E Mitchell, TR Kosten Pharmacology Biochemistry and Behavior 78 (4), 699-705, 2004 | 124 | 2004 |
| 7-Benzylidenenaltrexone (BNTX): a selective δ1 opioid receptor antagonist in the mouse spinal cord M Sofuoglu, PS Portoghese, AE Takemori Life sciences 52 (8), 769-775, 1993 | 117 | 1993 |
| The impact of cigarette smoking on stimulant addiction AH Weinberger, M Sofuoglu The American journal of drug and alcohol abuse 35 (1), 12-17, 2009 | 115 | 2009 |
Elise E. DeVitoYale UniversityVerified email at yale.edu
